Codexis, Inc.
(NASDAQ:CDXS)
President and CEO: John Nicols
CFO and SVP: Gordon Sangster
About: Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets. Its proven technologies enable scale-up and implementation of biocatalytic solutions to its customer needs for rapid, cost-effective and sustainable process development, from research to manufacturing. For more information, see www.codexis.com.
THIS INTERVIEW HAS EXPIRED